Investor Resources
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering
Registration statements relating to these securities have been filed with the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About
Contacts:
Chief Financial Officer
IR@crinetics.com
(858) 450-6464
Westwicke Partners
robert.uhl@westwicke.com
(858) 356-5932
Source: Crinetics Pharmaceuticals, Inc.